Merck settles Remeron case for $31M; Laser Spine Institute accused of paying for patients;

News From Around the Web

> Organon USA Inc., a subsidiary of Merck & Co., agreed to pay $31 million to resolve allegations of overcharging Medicaid programs for Remeron, an antidepressant sold at a discount to pharmacy companies, Reuters reported. Article

> One of the nation's largest back surgery centers, the Florida-based Laser Spine Institute, stands accused of offering illegal incentives to patients to attract new business, Bloomberg Businessweek reported. The provider says the lawsuit is based on "unproven allegations asserted by a competitor." Article

> To identify costly claims, monitoring data concurrently "for conditions that portend risk" and then intervening quickly may be a more practical methodology than predictive modeling, according to Insurance Thought Leadership. Article

Health Finance News

> Will the Affordable Care Act actually add to the deficit in the coming years? Congressional Republicans, according to a recent Forbes op-ed piece, are now asserting the ACA will add $131 billion to the federal deficit over the next decade, negating promises made by President Barack Obama. Article

> Medicaid enrollment has surged between October 2013 and the end of this August, rising by nearly 9 million overall. That has boosted total enrollment in the Medicaid program by 14.7 percent. Article

And Finally... Eighty cars fished from a river show "grand tradition" of insurance fraud. Article